CTO, Rich Goldstein, Named 2021 Digi-Tech Innovator Honoree

Morristown, NJ, April 23, 2021 --(PR.com)-- Cancer Expert Now is thrilled to announce Chief Technology Officer, Dr. Rich Goldstein, has been recognized as a 2021 Digi-Tech Innovator Honoree. This event recognizes innovators who have demonstrated excellence in technology leadership. Winners were honored during an awards ceremony held virtually Thursday, April 22 from 8:30-9:30am ET.

After receiving his bachelor’s degree in Biochemistry from UCLA, Dr. Goldstein earned his Medical Degree from the Albert Einstein College of Medicine of Yeshiva University in New York and completed Internal Medicine training at the Montefiore Hospital in Bronx, NY. Shortly after joining a group medical practice in 1997, Dr. Goldstein began developing a medical records software, and in 1998 Healthware Solutions, LLC was formed. This company provided one of the original web based EMR platforms to practices in the New York/New Jersey area. Dr. Goldstein developed and supported this software and company alongside his full-time medical practice. In 2010, Healthware Solutions, LLC was acquired by MD-Online, Inc., at which time Dr. Goldstein joined as Vice President, Medical Affairs and Clinical Products, and led the product team to develop and support two medical record software products until the company’s acquisition in 2014. From 2015-2016, Dr. Goldstein served as Director, Medical Informatics at Raritan Bay Medical Center, a 2-hospital system, in New Jersey. In 2016, Dr. Goldstein joined Cancer Expert Now, Inc. as Chief Technology Officer, and joined the company founders in filing a patent application for their expert engagement platform in 2019. He continues to serve as Chief Technology Officer.

As CTO of Cancer Expert Now, Rich designed our cutting-edge platform which allows premium access to expert insights while simultaneously minimizing barriers faced by all stakeholders. Rich was at the forefront of recognizing that gaining access to thought-leader level medical expertise, particularly in oncology, has traditionally been a long and at times difficult process. By creatively leveraging digital technologies, the platform he created is designed to engage and offer convenience for experts, by automating the difficult task of aligning the right expert or experts for the end user and eases the burdens of regulatory compliance. For the people we serve, access to elite-level expertise was shortened from weeks to hours. This has been true for both patients and community practitioners as well as pharma-industry stakeholders.

About Cancer Expert Now
Cancer Expert Now’s on-demand platform connects practicing oncologists, pharmaceutical executives, and patients to the world’s leading experts to discuss topics such as current disease challenges, recent literature, and global clinical findings in real time.